Table 1

No./Case No.	Sex	Age	TB drugs regimen	Months treated with ATT prior to V5	Smear Positive		Liver size in cm over normal		Erythrocyte sedimentation rate (ESR)		Leukocyte × 109 L		Hb g/L		Weight change kg		Total bilirubin μmol/L		ALT* μmol/ml•h
No./Case No.	Sex	Age	TB drugs regimen	Months treated with ATT prior to V5	before	after	before	after	before	after	before	after	before	after	before	after	before	after	before	after
1/602	M	33	RZSE	1	-	-	3	0	31	5	4.3	3.8	114	129	57	66	20	10	2.35	0.12
2/57	F	24	HRZSE	4	+	-	7	2	58	9	11.6	4.3	101	118	62	75	25	10	1.62	0.12
3/376	M	33	HRZSE	6	+	-	5	2	22	4	18.3	6	112	125	68	79	18	12	1.62	0.12
4/78	M	42	HRZSE	2	+	-	4	1	32	5	14	6.8	118	128	74	86	13	15	2.35	0.12
5/391	M	74	HRZSE	6	+	-	4	1	22	7	12.3	2.8	120	132	72	82	25	10	1.62	0.1
6/563	F	24	HRZSE	2	+	-	2	0	43	11	12	3.4	108	115	49	59	20	10	1.62	0.12
7/422	M	36	HRZSE	5	+	+	4	4	28	32	14	3.8	112	110	62	54	20	20	1.62	1.38
8/502	M	34	HRZSE	3	+	-	5	1	32	10	20	6	108	116	67	74	25	10	1.62	0.12
9/553	M	31	HRZSE	3	+	-	5	2	43	18	12	6	120	132	71	83	25	10	1.62	0.12
10/579	F	34	HRZSE	3	+	-	2	0	40	10	14.9	4	112	120	47	52	25	10	1.62	0.12
11/360	M	38	HRZSE	5	-	-	2	0	45	9	12	4	118	122	75	83	20	10	2.35	0.12
12/570	M	36	HRZSE	3	+	-	2	0	28	7	19	5	122	128	60	70	25	10	1.62	0.12
13/605	M	42	HRZSE	1	+	-	4	1	28	10	18	4	104	118	66	75	25	10	1.62	0.12
14/465	F	26	HRZSE	4	+	-	2	1	20	4	18	3	118	128	62	67	20	10	1.32	0.12
15/519	M	33	HRZSE	3	+	-	4	1	18	10	9	4	118	120	69	73	20	10	1.32	0.12
16/613	M	35	HRZSE	1	+	-	2	0	22	5	14	4	112	128	71	75	25	10	1.62	0.12
17/654	M	38	HRZSE	1	+	-	3	0	34	9	14	8	122	130	68	77	25	10	1.62	0.12
18/311	M	42	HRZSE	1	+	-	2	1	14	5	18	6	128	132	70	75	25	10	1.62	0.12
19/558	F	41	HRZSE	2	-	-	3	0	38	11	18	4	112	118	59	70	20	10	2.35	0.12
20/641	M	26	HRZSE	3	+	-	5	2	48	16	13	6	102	118	77	85	20	10	1.32	0.12
20	5/15	36.1 ±10.6			17	1	3.5 ±1.4	0.95 ±1.1	32.3 ±11.4	9.9 ±6.4	14.3± 3.9	4.7± 1.4	114 ±7.1	123.4 ±6.6	65.3 ±8.1	73 ±9.6	22.1 ±3.4	10.9 ±2.5	1.72 ±0.34	0.18 ±0.3
				Mean: 2.95 Median: 3	Fisher’s exact 2-way test P<0.000001		Mean decrease 2.55cm P=2.893E-009		Mean decrease 22.4 P=3.713E -008		Mean decrease 9.6x109L P=7.162E-010		Mean gain 9.3g/L P=1.419E-007		Mean gain 7.7 kg P=4.604E-007		Mean decrease 11.2 μmol/L P=5.679E-009		Mean decrease 1.54 μmol/ml•h P=5.027E-012

*ALT activity was determined according to Reitman & Frankel [25]; the normal range of ALT in this test is 0.1-0.68 µmol/ml•h
Table 1: Baseline and outcome characteristics of HCV-infected patients with HIV and TB co-infections treated with TB drugs in combination with V5 for one month.